Cargando…
Tolerising cellular therapies: what is their promise for autoimmune disease?
The current management of autoimmunity involves the administration of immunosuppressive drugs coupled to symptomatic and functional interventions such as anti-inflammatory therapies and hormone replacement. Given the chronic nature of autoimmunity, however, the ideal therapeutic strategy would be to...
Autores principales: | Mosanya, Chijioke H, Isaacs, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390030/ https://www.ncbi.nlm.nih.gov/pubmed/30389690 http://dx.doi.org/10.1136/annrheumdis-2018-214024 |
Ejemplares similares
-
Macrophage Subset Sensitivity to Endotoxin Tolerisation by Porphyromonas gingivalis
por: Foey, Andrew D., et al.
Publicado: (2013) -
“Negative Vaccination” by Specific CD4(+) T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses
por: Lang, Karl S., et al.
Publicado: (2007) -
Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip
por: Al-Shaghdali, Khalid, et al.
Publicado: (2019) -
Increased infiltration and tolerised antigen-specific CD8(+) T(EM) cells in tumor but not peripheral blood have no impact on survival of HCMV(+) glioblastoma patients
por: Bahador, M., et al.
Publicado: (2017) -
Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options
por: Zeng, Rachel, et al.
Publicado: (2022)